Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,437 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

NCT04711252

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Harbor City, California, United States
  • Research Site Solvang, California, United States
View all 263 locations
View Trial Details
Active, Not Recruiting

A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)

NCT04035486

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • Research Site Bellflower, California, United States
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Santa Monica, California, United States
View all 153 locations
View Trial Details
Active, Not Recruiting

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

NCT03383094

Conditions
Cancer, Cancer of Head and Neck, Cancer, Advanced, +35 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • H. Lee Moffitt Cancer Center & Research Facility Tampa, Florida, United States
  • Washington University School of Medicine, Siteman Cancer Center St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

NCT04365374

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +10 more
Locations
  • HonorHeath Scottsdale Osborn Medical Center Phoenix, Arizona, United States
  • University of Arkansas Medical Center Little Rock, Arkansas, United States
  • Ascension St. Vincent's- Riverside Jacksonville, Florida, United States
  • Baptist MD Anderson Cancer Center- Jacksonville Jacksonville, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

NCT03734029

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Ironwood Cancer & Research Centers - Chandler II Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Treatment Centers of America at Western Regional Medical Center Goodyear, Arizona, United States
  • UCLA School of Medicine Los Angeles, California, United States
View all 208 locations
View Trial Details
Active, Not Recruiting

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Advanced Solid Tumor, +27 more
Locations
  • Local Institution - 2102 La Jolla, California, United States
  • Local Institution - 2108 Orange, California, United States
  • Local Institution - 2105 Denver, Colorado, United States
  • Local Institution - 2111 Chicago, Illinois, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

NCT03785249

Conditions
Advanced Cancer, Colonic Diseases, Colonic Neoplasms, +20 more
Locations
  • Local Institution - 001-826 Birmingham, Alabama, United States
  • Local Institution - 001-965 Anchorage, Alaska, United States
  • Local Institution - 001-821 Phoenix, Arizona, United States
  • Local Institution - 001-873-A Tucson, Arizona, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

Phase III Radium 223 mCRPC-PEACE III

NCT02194842

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Hopital Universitaire Brugmann Brussels, Belgium
  • Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
View all 64 locations
View Trial Details
Active, Not Recruiting

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors

NCT03721341

Conditions
Metastatic Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Alfred Health Melbourne, Victoria, Australia
  • BC Cancer Agency, Vancouver Island Centre Victoria, British Columbia, Canada
  • Nova Scotia Health Authortiy Halifax, Nova Scotia, Canada
  • Health Sciences North Greater Sudbury, Ontario, Canada
View all 14 locations
View Trial Details
Active, Not Recruiting

HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)

NCT04257162

Conditions
Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • ICO Badalona Badalona, Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
  • Hospital Clínic de Barcelona Barcelona, Spain
  • Hospital Universitario de Jerez Jerez de la Frontera, Cadiz, Spain
View all 15 locations
View Trial Details

Related conditions